(1) |
MacGregor AG. Why does anybody use thyroid BP? Lancet 1961; 1: 329-32. |
(2) |
Gow SM, Caldwell G, Toft AD, et al. Relationship between
pituitary and other target organ responsiveness in hypothyroid patients
receiving thyroxine replacement. J Clin Endocrinol Metab 1987; 64: 364-70. |
(3) |
Nystrom E, Lundberg P-A, Petersen K, Bengtsson C, Lindstedt G. Evidence
for a slow tissue adaptation to circulating thyroxine in patients with chronic
L-thyroxine treatment. Clin Endocrinol 1989; 31: 143-50. |
(4) |
Gow SM, Caldwell G, Toft AD, Beckett GJ. Different hepatic responses to
thyroxine replacement in spontaneous and 131-I induced primary hypothyroidism,
Clin Endocrinol (Oxf) 1989; 30: 505-12. |
(5) |
Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH. American Thyroid
Association guidelines for use of laboratory tests in thyroid disorders.
JAMA 1990; 263: 1529-32. |
(6) |
Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations
as a risk factor for atrial fibrillation in older persons. N Engl J Med
1994; 331: 1249-52. |
(7) |
Carr D, McLeod DT, Parry G, Thornes HM. Fine adjustment of thyroxine replacement
dosage: comparison of the thyrotrophin releasing hormone test using a sensitive
thyrotrophin assay with measurement of free thyroid hormones and clinical
assessment. Clin Endocrinol(Oxf) 1988; 28: 325-33. |
(8) |
Escobar-Morreale HF, del Ray FE, Obregon MJ, de Escobar GM. Only the combined
treatment with thyroxine and triiodothyronine ensures euthyroidism in all
tissues of the thyroidectomized rat. Endocrinology 1996; 137: 2490-502. |
(9) |
Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of
thyroxine as compared with thyroxine plus triiodothyronine in patients with
hypothyroidism. N Engl J Med 1999; 340: 424-9. |